The IPO Buzz: Cancer-Focused Caris Life Sciences (CAI) Unveils $400 Million IPO
Caris Life Sciences, Inc. (CAI Proposed), a cancer-focused precision medicine pioneer, revealed its IPO terms – 23.53 million shares at a price range of $16.00 to $18.00 – to raise $400.0 million, if priced at the $17.00 mid-point of its range – in an S-1/A filing early today, Monday, June 9, 2025. At pricing, Caris Life Sciences would have a market cap of about $5.05 billion – assuming mi..
Read more June 9, 2025IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Ategrity Specialty Holdings | ASIC | 6.7 | $ 100.0 mil | 6/11/2025 Wednesday | S/O | S/O |
| Voyager Technologies, Inc. | VOYG | 11.0 | $ 302.5 mil | 6/11/2025 Wednesday | S/O | S/O |
| Chime Financial, Inc. | CHYM | 32.0 | $ 800.0 mil | 6/12/2025 Thursday | S/O | S/O |
Last 100 IPOs - June 9, 2025
| Number of IPOs priced : | 100 |
| Number Up: | 55 |
| Number Down: | 42 |
| Number Unchanged: | 3 |
| Percentage Change From Issue Price: | 21.47% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2025 IPO Scorecard - June 9, 2025
| Number of IPOs priced (Excluding 51 units) : | 98 |
| Number Up: | 54 |
| Number Down: | 41 |
| Number Unchanged: | 3 |
| Total Return From Issue Price: | 21.25% |
| The Nasdaq Composite Index YTD % Change | 35.22% |